Exercise does not activate the β3 adrenergic receptor–eNOS pathway, but reduces inducible NOS expression to protect the heart of obese diabetic mice

Basic Research in Cardiology

Volumn 111, Issue 4, 2016, Pages

  Kleindienst, Adrien ^a   Battault, Sylvain ^a   Belaidi, Elise ^b,c   Tanguy, Stephane ^d   Rosselin, Marie ^e   Boulghobra, Doria ^a   Meyer, Gregory ^a   Gayrard, Sandrine ^a   Walther, Guillaume ^a   Geny, Bernard ^f   Durand, Gregory ^e   Cazorla, Olivier ^g   Reboul, Cyril ^a  

^a UNIVERSITY OF AVIGNON   (France)

^b UNIV GRENOBLE ALPES   (France)

^c INSERM   (France)

^d LABORATOIRE TIMC IMAG   (France)

^e UNIVERSITÉ DE MONTPELLIER   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g UNIVERSITY OF MONTPELLIER   (France)

Author keywords

Cardioprotection; Exercise; Insulin resistance; Myocardial infarction; Nitric oxide; Type 2 diabetes; 3 Adrenergic receptor

Indexed keywords

3 NITROTYROSINE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; BETA 3 ADRENERGIC RECEPTOR; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; NITRITE; REACTIVE OXYGEN METABOLITE; SUCROSE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; ENDURANCE TRAINING; ENZYME ACTIVATION; ENZYME ACTIVITY; EX VIVO STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VIVO STUDY; LIPID DIET; MALE; MOUSE; NITROSATIVE STRESS; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; SEDENTARY LIFESTYLE; THERAPY EFFECT; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPLICATION; DISEASE MODEL; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, ADRENERGIC, BETA-3;

EID: 84971265336     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-016-0559-0     Document Type: Article

References (49)

1. Alegria JR, Miller TD, Gibbons RJ, Yi QL, Yusuf S, Collaborative Organization of RheothRx Evaluation (CORE) Trial Investigators (2007) Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy. Am Heart J 154:743–750. doi:10.1016/j.ahj.2007.06.020
2. 3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol 58:2683–2691. doi:10.1016/j.jacc.2011.09.033
3. 2+ and cell death during ischaemia-reperfusion injury in cardiomyocytes. J Physiol 587:1331–1341. doi:10.1113/jphysiol.2008.163311
4. Belaidi E, Thomas A, Bourdier G, Moulin S, Lemarié E, Levy P, Pépin JL, Korichneva I, Godin-Ribuot D, Arnaud C (2016) Endoplasmic reticulum stress as a novel inducer of hypoxia inducible factor-1 activity: its role in the susceptibility to myocardial ischemia-reperfusion induced by chronic intermittent hypoxia. Int J Cardiol 210:45–53. doi:10.1016/j.ijcard.2016.02.096
5. 3-adrenoceptor in altered beta-adrenergic response in senescent heart: role of nitric oxide synthase 1-derived nitric oxide. Anesthesiology 109:1045–1053. doi:10.1097/ALN.0b013e31818d7e5a
6. Bolli R (2007) Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 292:H19–H27. doi:10.1152/ajpheart.00712.2006
7. 3-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circ Res 108:1448–1458. doi:10.1161/CIRCRESAHA.111.241117
8. Farah C, Kleindienst A, Bolea G, Meyer G, Gayrard S, Geny B, Obert P, Cazorla O, Tanguy S, Reboul C (2013) Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites. Basic Res Cardiol 108:389. doi:10.1007/s00395-013-0389-2
9. Ferdinandy P, Hausenloy DJ, Heusch G, Baxter GF, Schulz R (2014) Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning. Pharmacol Rev 66:1142–1174. doi:10.1124/pr.113.008300
10. 3-adrenergic receptor expression in 3T3-F442A adipocytes: a mechanism for repressing the cAMP signaling pathway. Proc Natl Acad Sci USA 91:5677–5681
11. French JP, Hamilton KL, Quindry JC, Lee Y, Upchurch PA, Powers SK (2008) Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain. FASEB J Off Publ Fed Am Soc Exp Biol 22:2862–2871. doi:10.1096/fj.07-102541
12. 3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res Cardiol 109:422. doi:10.1007/s00395-014-0422-0
13. Gödecke A, Molojavyi A, Heger J, Flögel U, Ding Z, Jacoby C, Schrader J (2003) Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J Biol Chem 278:21761–21766. doi:10.1074/jbc.M302573200
14. Guo Y, Sanganalmath SK, Wu W, Zhu X, Huang Y, Tan W, Ildstad ST, Li Q, Bolli R (2012) Identification of inducible nitric oxide synthase in peripheral blood cells as a mediator of myocardial ischemia/reperfusion injury. Basic Res Cardiol 107:253. doi:10.1007/s00395-012-0253-9
15. Guo Y, Stein AB, Wu WJ, Zhu X, Tan W, Li Q, Bolli R (2005) Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and δ1-opioid receptor agonists is mediated by iNOS. Am J Physiol Heart Circ Physiol 289:H2251–H2257. doi:10.1152/ajpheart.00341.2005
16. 3-adrenergic receptor expression in rat adipose tissue during the fasted/fed transition: evidence for a role of insulin. Biochem J 323(Pt 2):359–364
17. von Harsdorf R, Li PF, Dietz R (1999) Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation 99:2934–2941
18. 3-adrenoceptor activation just says NO to myocardial reperfusion injury. J Am Coll Cardiol 58:2692–2694. doi:10.1016/j.jacc.2011.09.034
19. Hu A, Jiao X, Gao E, Koch WJ, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ (2006) Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress. J Pharmacol Exp Ther 318:469–475. doi:10.1124/jpet.106.102160
20. Huang JV, Lu L, Ye S, Bergman BC, Sparagna GC, Sarraf M, Reusch JEB, Greyson CR, Schwartz GG (2013) Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome. Am J Physiol Heart Circ Physiol 304:H861–H873. doi:10.1152/ajpheart.00535.2012
21. Idigo WO, Reilly S, Zhang MH, Zhang YH, Jayaram R, Carnicer R, Crabtree MJ, Balligand JL, Casadei B (2012) Regulation of endothelial nitric-oxide synthase (NOS) S-glutathionylation by neuronal NOS: evidence of a functional interaction between myocardial constitutive NOS isoforms. J Biol Chem 287:43665–43673. doi:10.1074/jbc.M112.412031
22. 3-adrenergic signaling on the adipokine leptin in cardiac myocytes. Int J Obes 36:876–879. doi:10.1038/ijo.2011.137
23. Lei P, Baysa A, Nebb HI, Valen G, Skomedal T, Osnes JB, Yang Z, Haugen F (2013) Activation of Liver X receptors in the heart leads to accumulation of intracellular lipids and attenuation of ischemia-reperfusion injury. Basic Res Cardiol 108:323. doi:10.1007/s00395-012-0323-z
24. Lekli I, Szabo G, Juhasz B, Das S, Das M, Varga E, Szendrei L, Gesztelyi R, Varadi J, Bak I, Das DK, Tosaki A (2008) Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am J Physiol Heart Circ Physiol 294:H859–H866. doi:10.1152/ajpheart.01048.2007
25. Levantesi G, Macchia A, Marfisi R, Franzosi MG, Maggioni AP, Nicolosi GL, Schweiger C, Tavazzi L, Tognoni G, Valagussa F, Marchioli R, GISSI-Prevenzione Investigators (2005) Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol 46:277–283. doi:10.1016/j.jacc.2005.03.062
26. Li Q, Guo Y, Ou Q, Cui C, Wu WJ, Tan W, Zhu X, Lanceta LB, Sanganalmath SK, Dawn B, Shinmura K, Rokosh GD, Wang S, Bolli R (2009) Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation 120:1222–1230. doi:10.1161/CIRCULATIONAHA.108.778688
27. Lund J, Hafstad AD, Boardman NT, Rossvoll L, Rolim NP, Ahmed MS, Florholmen G, Attramadal H, Wisløff U, Larsen TS, Aasum E (2015) Exercise training promotes cardioprotection through oxygen-sparing action in high fat-fed mice. Am J Physiol Heart Circ Physiol 308:H823–H829. doi:10.1152/ajpheart.00734.2014
28. Marso SP, Miller T, Rutherford BD, Gibbons RJ, Qureshi M, Kalynych A, Turco M, Schultheiss HP, Mehran R, Krucoff MW, Lansky AJ, Stone GW (2007) Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial). Am J Cardiol 100:206–210. doi:10.1016/j.amjcard.2007.02.080
29. Meyer G, André L, Kleindienst A, Singh F, Tanguy S, Richard S, Obert P, Boucher F, Jover B, Cazorla O, Reboul C (2015) Carbon monoxide increases inducible NOS expression that mediates CO-induced myocardial damage during ischemia-reperfusion. Am J Physiol Heart Circ Physiol 308:H759–H767. doi:10.1152/ajpheart.00702.2014
30. Meyer G, André L, Tanguy S, Boissiere J, Farah C, Lopez-Lauri F, Gayrard S, Richard S, Boucher F, Cazorla O, Obert P, Reboul C (2010) Simulated urban carbon monoxide air pollution exacerbates rat heart ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298:H1445–H1453. doi:10.1152/ajpheart.01194.2009
31. Miki T, Itoh T, Sunaga D, Miura T (2012) Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol 11:67. doi:10.1186/1475-2840-11-67
32. Mozaffari MS, Schaffer SW (2008) Myocardial ischemic-reperfusion injury in a rat model of metabolic syndrome. Obes Silver Spring Md 16:2253–2258. doi:10.1038/oby.2008.356
33. Nduhirabandi F, Du Toit EF, Blackhurst D, Marais D, Lochner A (2011) Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 50:171–182. doi:10.1111/j.1600-079X.2010.00826.x
34. Nistri S, Boccalini G, Bencini A, Becatti M, Valtancoli B, Conti L, Lucarini L, Bani D (2015) A new low molecular weight, MnII-containing scavenger of superoxide anion protects cardiac muscle cells from hypoxia/reoxygenation injury. Free Radic Res 49:67–77. doi:10.3109/10715762.2014.979168
35. 3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59:1979–1987. doi:10.1016/j.jacc.2011.12.046
36. Osipov RM, Bianchi C, Feng J, Clements RT, Liu Y, Robich MP, Glazer HP, Sodha NR, Sellke FW (2009) Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion. Circulation 120:S22–S30. doi:10.1161/CIRCULATIONAHA.108.842724
37. Pons S, Martin V, Portal L, Zini R, Morin D, Berdeaux A, Ghaleh B (2013) Regular treadmill exercise restores cardioprotective signaling pathways in obese mice independently from improvement in associated co-morbidities. J Mol Cell Cardiol 54:82–89. doi:10.1016/j.yjmcc.2012.11.010
38. Powers SK, Smuder AJ, Kavazis AN, Quindry JC (2014) Mechanisms of exercise-induced cardioprotection. Physiol Bethesda Md 29:27–38. doi:10.1152/physiol.00030.2013
39. Przyklenk K (2011) Efficacy of cardioprotective “conditioning” strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging 28:331–343. doi:10.2165/11587190-000000000-00000
40. Roof SR, Ho HT, Little SC, Ostler JE, Brundage EA, Periasamy M, Villamena FA, Györke S, Biesiadecki BJ, Heymes C, Houser SR, Davis JP, Ziolo MT (2015) Obligatory role of neuronal nitric oxide synthase in the heart’s antioxidant adaptation with exercise. J Mol Cell Cardiol 81:54–61. doi:10.1016/j.yjmcc.2015.01.003
41. Soliman H, Craig GP, Nagareddy P, Yuen VG, Lin G, Kumar U, McNeill JH, Macleod KM (2008) Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Cardiovasc Res 79:322–330. doi:10.1093/cvr/cvn095
42. Song D, Kuo KH, Yao R, Hutchings SR, Pang CCY (2008) Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats. Eur J Pharmacol 579:253–259. doi:10.1016/j.ejphar.2007.09.043
43. 3-adrenergic receptor. Cardiovasc Res 59:288–296
44. 1-blocker therapy. Basic Res Cardiol 110:456. doi:10.1007/s00395-014-0456-3
45. Wang T, Mao X, Li H, Qiao S, Xu A, Wang J, Lei S, Liu Z, Ng KFJ, Wong GT, Vanhoutte PM, Irwin MG, Xia Z (2013) N-Acetylcysteine and allopurinol up-regulated the Jak/STAT3 and PI3K/Akt pathways via adiponectin and attenuated myocardial postischemic injury in diabetes. Free Radic Biol Med 63:291–303. doi:10.1016/j.freeradbiomed.2013.05.043
46. Wang XL, Liu HR, Tao L, Liang F, Yan L, Zhao RR, Lopez BL, Christopher TA, Ma XL (2007) Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion. Apoptosis Int J Program Cell Death 12:1209–1217. doi:10.1007/s10495-007-0055-y
47. Wang Y, Guo Y, Zhang SX, Wu WJ, Wang J, Bao W, Bolli R (2002) Ischemic preconditioning upregulates inducible nitric oxide synthase in cardiac myocyte. J Mol Cell Cardiol 34:5–15. doi:10.1006/jmcc.2001.1482
48. Weidinger A, Müllebner A, Paier-Pourani J, Banerjee A, Miller I, Lauterböck L, Duvigneau JC, Skulachev VP, Redl H, Kozlov AV (2015) Vicious inducible nitric oxide synthase-mitochondrial reactive oxygen species cycle accelerates inflammatory response and causes liver injury in rats. Antioxid Redox Signal 22:572–586. doi:10.1089/ars.2014.5996
49. Yi W, Sun Y, Gao E, Wei X, Lau WB, Zheng Q, Wang Y, Yuan Y, Wang X, Tao L, Li R, Koch W, Ma XL (2011) Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms. Antioxid Redox Signal 15:1779–1788. doi:10.1089/ars.2010.3722